Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5899]

Researchers identify how enzyme affects infertility and cancer progression

Researchers identify how enzyme affects infertility and cancer progression

Drugging the undruggable: Scientists achieve million-fold leap in targeting elusive cancer proteins

Drugging the undruggable: Scientists achieve million-fold leap in targeting elusive cancer proteins

Proteomics-driven precision oncology: from molecular profiling to biomarker discovery

Proteomics-driven precision oncology: from molecular profiling to biomarker discovery

The beating of the heart suppresses growth in cardiac cancers

The beating of the heart suppresses growth in cardiac cancers

New targeted therapy shows promise against aggressive childhood and adult cancers

New targeted therapy shows promise against aggressive childhood and adult cancers

Discovery of a novel vulnerability in aggressive lymphoma could change future therapy

Discovery of a novel vulnerability in aggressive lymphoma could change future therapy

AACR 2026: Researchers define a mechanism‑driven strategy for targeting p53‑mutant cancers

AACR 2026: Researchers define a mechanism‑driven strategy for targeting p53‑mutant cancers

Exploiting a new vulnerability that targets 'zombie’ cells as an anticancer therapy

Exploiting a new vulnerability that targets 'zombie’ cells as an anticancer therapy

Extra sets of chromosomes may help aggressive tumour cells spread, study finds

Extra sets of chromosomes may help aggressive tumour cells spread, study finds

$Tovorafenib approved in the EU as the first targeted therapy in relapsed or refractory paediatric low-grade glioma regardless of BRAF alteration$

Tovorafenib approved in the EU as the first targeted therapy in relapsed or refractory paediatric low-grade glioma...

More from ecancer